Christoph Kreer

2.2k total citations
17 papers, 500 citations indexed

About

Christoph Kreer is a scholar working on Infectious Diseases, Immunology and Molecular Biology. According to data from OpenAlex, Christoph Kreer has authored 17 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Christoph Kreer's work include SARS-CoV-2 and COVID-19 Research (7 papers), Immunotherapy and Immune Responses (5 papers) and COVID-19 Clinical Research Studies (4 papers). Christoph Kreer is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), Immunotherapy and Immune Responses (5 papers) and COVID-19 Clinical Research Studies (4 papers). Christoph Kreer collaborates with scholars based in Germany, United States and France. Christoph Kreer's co-authors include Florian Klein, Henning Gruell, Matthias Zehner, Kanika Vanshylla, Sven Burgdorf, Timm Weber, Philipp Schommers, Christopher O. Barnes, Ferry Ossendorp and Erik Bos and has published in prestigious journals such as Nature Medicine, Nature Communications and Immunity.

In The Last Decade

Christoph Kreer

17 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christoph Kreer Germany 12 218 208 162 68 65 17 500
Matthias Zehner Germany 11 141 0.6× 241 1.2× 159 1.0× 71 1.0× 53 0.8× 15 453
Sietske K. Rosendahl Huber Netherlands 8 154 0.7× 195 0.9× 150 0.9× 149 2.2× 24 0.4× 8 381
Richard M. Hooy United States 9 242 1.1× 439 2.1× 389 2.4× 73 1.1× 27 0.4× 11 710
Suzanne Pickering United Kingdom 12 294 1.3× 346 1.7× 157 1.0× 187 2.8× 17 0.3× 18 738
Jared Sheehan United States 6 200 0.9× 131 0.6× 138 0.9× 141 2.1× 143 2.2× 7 479
Gretel M. Torres United States 4 309 1.4× 100 0.5× 166 1.0× 31 0.5× 153 2.4× 5 502
Benedikt Asbach Germany 11 132 0.6× 75 0.4× 190 1.2× 77 1.1× 29 0.4× 28 373

Countries citing papers authored by Christoph Kreer

Since Specialization
Citations

This map shows the geographic impact of Christoph Kreer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Kreer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Kreer more than expected).

Fields of papers citing papers by Christoph Kreer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Kreer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Kreer. The network helps show where Christoph Kreer may publish in the future.

Co-authorship network of co-authors of Christoph Kreer

This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Kreer. A scholar is included among the top collaborators of Christoph Kreer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Kreer. Christoph Kreer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Asen, Theresa, Wenshi Wang, Anindita Chakraborty, et al.. (2024). CARs derived from broadly neutralizing, human monoclonal antibodies identified by single B cell sorting target hepatitis B virus-positive cells. Frontiers in Immunology. 15. 1340619–1340619. 4 indexed citations
2.
Weber, Timm, S. Rose, Kanika Vanshylla, et al.. (2023). Enhanced SARS-CoV-2 humoral immunity following breakthrough infection builds upon the preexisting memory B cell pool. Science Immunology. 8(89). eadk5845–eadk5845. 15 indexed citations
3.
Korenkov, Michael, Matthias Zehner, Hadas Cohen‐Dvashi, et al.. (2023). Somatic hypermutation introduces bystander mutations that prepare SARS-CoV-2 antibodies for emerging variants. Immunity. 56(12). 2803–2815.e6. 16 indexed citations
4.
Kreer, Christoph, Meryem S. Ercanoglu, Lutz Gieselmann, et al.. (2023). Probabilities of developing HIV-1 bNAb sequence features in uninfected and chronically infected individuals. Nature Communications. 14(1). 7137–7137. 7 indexed citations
5.
Gruell, Henning, Kanika Vanshylla, Michael Korenkov, et al.. (2022). SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns. Cell Host & Microbe. 30(9). 1231–1241.e6. 46 indexed citations
6.
Ercanoglu, Meryem S., Lutz Gieselmann, Manuel Koch, et al.. (2022). No substantial preexisting B cell immunity against SARS-CoV-2 in healthy adults. iScience. 25(3). 103951–103951. 6 indexed citations
7.
Gruell, Henning, Kanika Vanshylla, Timm Weber, et al.. (2022). Antibody-mediated neutralization of SARS-CoV-2. Immunity. 55(6). 925–944. 76 indexed citations
8.
Gieselmann, Lutz, Christoph Kreer, Meryem S. Ercanoglu, et al.. (2021). Effective high-throughput isolation of fully human antibodies targeting infectious pathogens. Nature Protocols. 16(7). 3639–3671. 31 indexed citations
9.
Kreer, Christoph, et al.. (2020). Exploiting B Cell Receptor Analyses to Inform on HIV-1 Vaccination Strategies. Vaccines. 8(1). 13–13. 14 indexed citations
10.
Kreer, Christoph, Matthias Döring, Meryem S. Ercanoglu, et al.. (2020). openPrimeR for multiplex amplification of highly diverse templates. Journal of Immunological Methods. 480. 112752–112752. 22 indexed citations
11.
Zehner, Matthias, Verena Krähling, Hadas Cohen‐Dvashi, et al.. (2019). Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV. Nature Medicine. 25(10). 1589–1600. 65 indexed citations
12.
Döring, Matthias, et al.. (2019). Modeling the Amplification of Immunoglobulins through Machine Learning on Sequence-Specific Features. Scientific Reports. 9(1). 10748–10748. 6 indexed citations
13.
Kreer, Christoph, Matthias Zehner, Thomas Quast, et al.. (2016). N-glycosylation converts non-glycoproteins into mannose receptor ligands and reveals antigen-specific T cell responses in vivo. Oncotarget. 8(4). 6857–6872. 12 indexed citations
14.
Zehner, Matthias, Andrea L. J. Marschall, Erik Bos, et al.. (2015). The Translocon Protein Sec61 Mediates Antigen Transport from Endosomes in the Cytosol for Cross-Presentation to CD8+ T Cells. Immunity. 42(5). 850–863. 133 indexed citations
15.
Kreer, Christoph, Suzanne van Duikeren, Willemien E. Benckhuijsen, et al.. (2014). Enhanced Cross-Presentation and Improved CD8+ T Cell Responses after Mannosylation of Synthetic Long Peptides in Mice. PLoS ONE. 9(8). e103755–e103755. 24 indexed citations
16.
Kreer, Christoph, et al.. (2012). Cross-presentation: How to get there – or how to get the ER. Molecular Immunology. 51(1). 37–38. 4 indexed citations
17.
Kreer, Christoph. (2012). Cross-presentation: how to get there – or how to get the ER. Frontiers in Immunology. 2. 87–87. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026